Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation
摘要:
Continuing studies based on dihydroquinoline glucocorticoid receptor agonists lead to the discovery of a series of C4-oxime analogs. Representative compounds exhibited potent transrepression activity with minimal transactivation of phosphoenolpyruvate caboxykinase (PEPCK), a key protein in the gluconeogenesis pathway. These compounds represent promising leads in identifying GR agonists with high anti-inflammatory activity and attenuated potential for glucose elevation. (C) 2011 Elsevier Ltd. All rights reserved.
A series of 1,5-diarylpyrazoles with a substituted benzenesulfonamide moiety was synthesized and evaluated for cyclooxygenase (COX-1/COX-2) inhibitory activities. Some compounds, for example, (+/-)-2-[4-(5-p-tolyl-3-trifluoromethyl-pyrazole-1-yl)-benzenesulfonylaminooxy]-propionic acid 16 and its disodium salt 21, had a higher in vivo anti-inflammatory activity compared to celecoxib, despite having no in vitro COX-1 or COX-2 inhibitory activity. Their gastrointestinal side effect profile is essentially more favorable than that of celecoxib.
Werner; Bial, Chemische Berichte, 1895, vol. 28, p. 1374
作者:Werner、Bial
DOI:——
日期:——
HUBER, ERASMUS;KLEIN, CHRISTIAN;PAPPERT, GUNTER;HALLERMAYER, KLAUS
作者:HUBER, ERASMUS、KLEIN, CHRISTIAN、PAPPERT, GUNTER、HALLERMAYER, KLAUS
DOI:——
日期:——
CIMARUSTI, C. M.;FOX, R. T.;FRITZ, A. W.;KOSTER, W. H.;MONIOT, J. L.
作者:CIMARUSTI, C. M.、FOX, R. T.、FRITZ, A. W.、KOSTER, W. H.、MONIOT, J. L.